{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:36:20Z","timestamp":1793417780028,"version":"4.5.0"},"publisher-location":"Chichester, UK","reference-count":91,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd007107.pub2","type":"reference-entry","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T17:26:21Z","timestamp":1233681981000},"source":"Crossref","is-referenced-by-count":42,"title":["Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy"],"prefix":"10.1002","author":[{"given":"Christine","family":"Herbst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Brigitta","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Monsef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bohlius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"10.1002\/14651858.CD007107.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/43.5.741","article-title":"Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B","volume":"43","author":"Schroder","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1054\/bjoc.2001.2114","article-title":"A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics","volume":"85","author":"Sculier","year":"2001","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/bjc.1994.71","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer","volume":"69","author":"Ardizzoni","year":"1994","journal-title":"British Journal of Cancer"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2402218","article-title":"Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia","volume":"15","author":"Bradstock","year":"2001","journal-title":"Leukemia"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/sj.bjc.6602975","article-title":"A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma","volume":"94","author":"Burton","year":"2006","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<331::AID-MPO4>3.0.CO;2-M","article-title":"Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemia","volume":"32","author":"Clarke","year":"1999","journal-title":"Medical & Pediatric Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0609.1995.tb01816.x","article-title":"Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial","volume":"55","author":"Dibenedetto","year":"1995","journal-title":"European Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1600-0609.2006.00741.x","article-title":"Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial","volume":"77","author":"Faber","year":"2006","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB9|cit9","unstructured":"Garcia G Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: Results of a randomized study Revista Espanola de Quimioterapia 2000 257 63"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub2-BIB10|cit10","first-page":"257","article-title":"Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study","volume":"15","author":"Garcia-Saenz","year":"2002","journal-title":"Revista Espanola de Quimioterapia"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/blood.V90.2.590","article-title":"Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study","volume":"90","author":"Geissler","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/sj.bmt.1704699","article-title":"A prospective randomized study of clinical and economic consequences of using G-CSF following autologous peripheral blood progenitor cell (PBPC) transplantation in children","volume":"34","author":"Gonzalez-Vicent","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB13|cit13","first-page":"1057","article-title":"GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation","volume":"18","author":"Greenberg","year":"1996","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-116-3-177","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) as adjunct therapy in relapsed Hodgkin disease","volume":"116","author":"Gulati","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1200\/JCO.2003.07.129","article-title":"Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study","volume":"21","author":"Heath","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1182\/blood.V90.12.4710","article-title":"A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group","volume":"90","author":"Heil","year":"1997","journal-title":"Blood"},{"key":"10.1002\/14651858.CD007107.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1200\/JCO.1996.14.11.2976","article-title":"Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer","volume":"14","author":"Jones","year":"1996","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00520-004-0658-6","article-title":"A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia","volume":"12","author":"Lalami","year":"2004","journal-title":"Supportive Care in Cancer"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/bjc.1998.216","article-title":"Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost","volume":"77","author":"Lee","year":"1998","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mpo.1279","article-title":"A randomised study of prophylactic G-CSF following MRC UKALL XI intensification regimen in childhood ALL and T-NHL","volume":"38","author":"Little","year":"2002","journal-title":"Medical & Pediatric Oncology"},{"issue":"10","key":"10.1002\/14651858.CD007107.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0959-8049(93)90011-4","article-title":"Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients","volume":"29A","author":"Maiche","year":"1993","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1200\/JCO.1997.15.2.451","article-title":"Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit (Structured abstract)","volume":"15","author":"McQuaker","year":"1997","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD007107.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1200\/JCO.2000.18.7.1517","article-title":"Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia","volume":"18","author":"Michel","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1200\/JCO.1994.12.1.77","article-title":"Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer","volume":"12","author":"Miles","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB25|cit25","first-page":"949","article-title":"Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation","volume":"15","author":"Nemunaitis","year":"1995","journal-title":"Bone Marrow Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007107.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2141.2007.06587.x","article-title":"Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue","volume":"137","author":"Nolan","year":"2007","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/sj.bmt.1701972","article-title":"A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults","volume":"24","author":"Ojeda","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1182\/blood.V86.2.444.bloodjournal862444","article-title":"Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial","volume":"86","author":"Ottmann","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.20.2.441","article-title":"Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology","volume":"20","author":"Patte","year":"2002","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood.V80.6.1430.1430","article-title":"Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial","volume":"80","author":"Pettengell","year":"1992","journal-title":"Blood"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.bmt.1701795","article-title":"Optimal timing of G-CSF administration after CD34+ immunoselected peripheral blood progenitor cell transplantation","volume":"23","author":"Piccirillo","year":"1999","journal-title":"Bone Marrow Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V97.11.3405","article-title":"Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors","volume":"97","author":"Przepiorka","year":"2001","journal-title":"Blood"},{"issue":"25","key":"10.1002\/14651858.CD007107.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199706193362503","article-title":"Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia","volume":"336","author":"Pui","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.bmt.1704724","article-title":"Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial","volume":"34","author":"Schmitz","year":"2004","journal-title":"Bone Marrow Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.1994.12.4.661","article-title":"Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit","volume":"12","author":"Spitzer","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1200\/JCO.1994.12.9.1931","article-title":"Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies","volume":"12","author":"Stahel","year":"1994","journal-title":"Journal of Clinical Oncology"},{"issue":"31","key":"10.1002\/14651858.CD007107.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1200\/JCO.2004.00.7955","article-title":"Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study","volume":"23","author":"Timmer-Bonte","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/annonc\/mdg073","article-title":"Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)","volume":"14","author":"Tjan-Heijnen","year":"2003","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1399-3046.2000.00101.x","article-title":"Administration of recombinant human granulocyte-macrophage colony-stimulating factor to children undergoing allogeneic marrow transplantation: a prospective, randomized, double-masked, placebo-controlled trial","volume":"4","author":"Trigg","year":"2000","journal-title":"Pediatric Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1182\/blood.V87.8.3143.bloodjournal8783143","article-title":"A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Munster Study Group","volume":"87","author":"Welte","year":"1996","journal-title":"Blood"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub2-BIB41|cit41","first-page":"2722","article-title":"A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM)","volume":"91","author":"Witz","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<289::AID-AJH7>3.0.CO;2-S","article-title":"Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin","volume":"51","author":"Yau","year":"1996","journal-title":"American Journal of Hematology"},{"issue":"11","key":"10.1002\/14651858.CD007107.pub2-BIB43|cit43","first-page":"3974","article-title":"Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma","volume":"89","author":"Zinzani","year":"1997","journal-title":"Blood"},{"issue":"15","key":"10.1002\/14651858.CD007107.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","article-title":"EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours","volume":"42","author":"Aapro","year":"2006","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD007107.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD007107.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(86)90510-3","article-title":"Infection in cancer patients. A continuing association","volume":"81","author":"Bodey","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub2-BIB47|cit47","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003189.pub4","article-title":"Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma","author":"Bohlius","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007107.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/bjc.1988.163","article-title":"In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients","volume":"58","author":"Bronchud","year":"1988","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD007107.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":". Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007107.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/clinids\/20.3.557","article-title":"Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin","volume":"20","author":"Carratala","year":"1995","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD007107.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.2005.05.645","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials","volume":"23","author":"Clark","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","article-title":"Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer","volume":"325","author":"Crawford","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007107.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1200\/JCO.2003.01.234","article-title":"Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients","volume":"21","author":"Cruciani","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMoa050078","article-title":"Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas","volume":"353","author":"Cullen","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007107.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"7109","key":"10.1002\/14651858.CD007107.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD007107.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s005200100300","article-title":"Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices","volume":"10","author":"Elting","year":"2002","journal-title":"Support Care Cancer"},{"key":"10.1002\/14651858.CD007107.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1200\/JCO.1998.16.3.1179","article-title":"Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis","volume":"16","author":"Engels","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkl425","article-title":"Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis","volume":"59","author":"Gafter-Gvili","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007107.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/stem.5530080705","article-title":"The biology of GM-CSF: regulation of production and interaction with its receptor","volume":"8 Suppl 1","author":"Griffin","year":"1990","journal-title":"International Journal of Cell Cloning"},{"key":"10.1002\/14651858.CD007107.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/sj.bjc.6601708","article-title":"Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?","volume":"90","author":"Hackshaw","year":"2004","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD007107.pub2-BIB63|cit63","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008] http:\/\/www.cochrane.org\/resources\/handbook\/"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/annonc\/mdf130","article-title":"Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer","volume":"13","author":"Holmes","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2000.18.13.2522","article-title":"Randomized, dose-escalation study of SD\/01 compared with daily filgrastim in patients receiving chemotherapy","volume":"18","author":"Johnston","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1200\/JCO.1996.14.11.2976","article-title":"Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer","volume":"14","author":"Jones","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-106-1-1","article-title":"Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial","volume":"106","author":"Karp","year":"1987","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD007107.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"issue":"21","key":"10.1002\/14651858.CD007107.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review","volume":"25","author":"Kuderer","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"7568","key":"10.1002\/14651858.CD007107.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","article-title":"The case of the misleading funnel plot","volume":"333","author":"Lau","year":"2006","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD007107.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD007107.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.1995.13.1.239","article-title":"Ciprofloxacin versus trimethoprim\/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial","volume":"13","author":"Lew","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0002-9343(02)01036-7","article-title":"Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: A meta-analysis","volume":"112","author":"Lyman","year":"2002","journal-title":"American Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1517\/14712598.5.12.1635","article-title":"Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action.","volume":"5","author":"Lyman","year":"2005","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1002\/14651858.CD007107.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. Quality of reporting of meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007107.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00784-002-0188-x","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"7","author":"Moher","year":"2003","journal-title":"Clinical Oral Investigation"},{"key":"10.1002\/14651858.CD007107.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(88)91475-4","article-title":"Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy","volume":"1","author":"Morstyn","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007107.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17(24)","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4065\/80.9.1122","article-title":"Systematic reviews and meta-analysis of febrile neutropenia","volume":"80","author":"Paul","year":"2005","journal-title":"Mayo Clinical Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD007107.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1185\/030079907X219599","article-title":"Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials","volume":"23","author":"Pinto","year":"2007","journal-title":"Current Medical Research & Opinion"},{"issue":"12","key":"10.1002\/14651858.CD007107.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM199909163411207","article-title":"Fever in immunocompromised patients","volume":"341","author":"Pizzo","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub2-BIB82|cit82","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006501.pub2","article-title":"Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation","author":"Raanani","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007107.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/jac\/30.5.730","article-title":"Superinfections by Escherichia coli resistant to fluoroquinolones in immunocompromised patients","volume":"30","author":"Somolinos","year":"1992","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD007107.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2004.09.106","article-title":"Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: A meta-analysis of randomized controlled trials","volume":"22","author":"Sung","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1002\/14651858.CD007107.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-147-6-200709180-00010","article-title":"Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection","volume":"147","author":"Sung","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD007107.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"31","key":"10.1002\/14651858.CD007107.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1200\/JCO.2004.00.7955","article-title":"Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study","volume":"23","author":"Timmer-Bonte","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD007107.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0959-8049(93)90376-Q","article-title":"Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy","volume":"29A","author":"Trillet-Lenoir","year":"1993","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD007107.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/annonc\/mdm438","article-title":"Pegfilgrastim +\/- ciprofloxacin for primary prophylaxis with TAC (docetaxel\/doxorubicin\/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study","volume":"19","author":"Minckwitz","year":"2008","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1002\/14651858.CD007107.pub2-BIB91|cit91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ctrv.2006.03.002","article-title":"Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials","volume":"32","author":"Wittman","year":"2006","journal-title":"Cancer Treatment Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007107.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,12,21]],"date-time":"2015-12-21T00:00:00Z","timestamp":1450656000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007107.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:07:11Z","timestamp":1628546831000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007107.pub2"}},"subtitle":[],"editor":[{"given":"Christine","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":91,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007107.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007107.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,1,21]]}}}